702 related articles for article (PubMed ID: 23048072)
1. S100A1 deficiency impairs postischemic angiogenesis via compromised proangiogenic endothelial cell function and nitric oxide synthase regulation.
Most P; Lerchenmüller C; Rengo G; Mahlmann A; Ritterhoff J; Rohde D; Goodman C; Busch CJ; Laube F; Heissenberg J; Pleger ST; Weiss N; Katus HA; Koch WJ; Peppel K
Circ Res; 2013 Jan; 112(1):66-78. PubMed ID: 23048072
[TBL] [Abstract][Full Text] [Related]
2. Role of serotonin in angiogenesis: induction of angiogenesis by sarpogrelate via endothelial 5-HT1B/Akt/eNOS pathway in diabetic mice.
Iwabayashi M; Taniyama Y; Sanada F; Azuma J; Iekushi K; Kusunoki H; Chatterjee A; Okayama K; Rakugi H; Morishita R
Atherosclerosis; 2012 Feb; 220(2):337-42. PubMed ID: 22172591
[TBL] [Abstract][Full Text] [Related]
3. Low molecular-weight fucoidan protects against hindlimb ischemic injury in type 2 diabetic mice through enhancing endothelial nitric oxide synthase phosphorylation.
Liu T; Wang Z; Chen X; You H; Xue J; Cai D; Zheng Y; Xu Y; Luo D
J Diabetes; 2018 Nov; 10(11):820-834. PubMed ID: 29633569
[TBL] [Abstract][Full Text] [Related]
4. BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis.
Singh KK; Shukla PC; Quan A; Al-Omran M; Lovren F; Pan Y; Brezden-Masley C; Ingram AJ; Stanford WL; Teoh H; Verma S
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):949-960.e4. PubMed ID: 23415688
[TBL] [Abstract][Full Text] [Related]
5. Waon therapy upregulates Hsp90 and leads to angiogenesis through the Akt-endothelial nitric oxide synthase pathway in mouse hindlimb ischemia.
Miyauchi T; Miyata M; Ikeda Y; Akasaki Y; Hamada N; Shirasawa T; Furusho Y; Tei C
Circ J; 2012; 76(7):1712-21. PubMed ID: 22481103
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor promotes sex-independent angiogenesis in response to ischemia and is required for activation of vascular endothelial growth factor receptor signaling.
Yoshida S; Aihara K; Ikeda Y; Sumitomo-Ueda Y; Uemoto R; Ishikawa K; Ise T; Yagi S; Iwase T; Mouri Y; Sakari M; Matsumoto T; Takeyama K; Akaike M; Matsumoto M; Sata M; Walsh K; Kato S; Matsumoto T
Circulation; 2013 Jul; 128(1):60-71. PubMed ID: 23723256
[TBL] [Abstract][Full Text] [Related]
7. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Promotes Angiogenesis and Ischemia-Induced Neovascularization Via NADPH Oxidase 4 (NOX4) and Nitric Oxide-Dependent Mechanisms.
Di Bartolo BA; Cartland SP; Prado-Lourenco L; Griffith TS; Gentile C; Ravindran J; Azahri NS; Thai T; Yeung AW; Thomas SR; Kavurma MM
J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26572549
[TBL] [Abstract][Full Text] [Related]
8. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
Sahara M; Sata M; Morita T; Nakajima T; Hirata Y; Nagai R
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734
[TBL] [Abstract][Full Text] [Related]
9. Diallyl Trisulfide Augments Ischemia-Induced Angiogenesis via an Endothelial Nitric Oxide Synthase-Dependent Mechanism.
Hayashida R; Kondo K; Morita S; Unno K; Shintani S; Shimizu Y; Calvert JW; Shibata R; Murohara T
Circ J; 2017 May; 81(6):870-878. PubMed ID: 28216514
[TBL] [Abstract][Full Text] [Related]
10. Metformin stimulates ischemia-induced revascularization through an eNOS dependent pathway in the ischemic hindlimb mice model.
Takahashi N; Shibata R; Ouchi N; Sugimoto M; Murohara T; Komori K
J Vasc Surg; 2015 Feb; 61(2):489-96. PubMed ID: 24993950
[TBL] [Abstract][Full Text] [Related]
11. Tubeimoside I promotes angiogenesis via activation of eNOS-VEGF signaling pathway.
Yang X; Li X; Luo M; Guo Y; Li C; Lv D; Cheng Z; Huang L; Shang FF; Huang B; Shen J; Luo S; Yan J
J Ethnopharmacol; 2021 Mar; 267():113642. PubMed ID: 33264658
[TBL] [Abstract][Full Text] [Related]
12. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
[TBL] [Abstract][Full Text] [Related]
13. Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis.
Lin YC; Chao TY; Yeh CT; Roffler SR; Kannagi R; Yang RB
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):144-155. PubMed ID: 27834687
[TBL] [Abstract][Full Text] [Related]
14. Nucleoside diphosphate kinase B regulates angiogenesis through modulation of vascular endothelial growth factor receptor type 2 and endothelial adherens junction proteins.
Feng Y; Gross S; Wolf NM; Butenschön VM; Qiu Y; Devraj K; Liebner S; Kroll J; Skolnik EY; Hammes HP; Wieland T
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2292-300. PubMed ID: 25147336
[TBL] [Abstract][Full Text] [Related]
15. Endothelial Cell Autonomous Role of Akt1: Regulation of Vascular Tone and Ischemia-Induced Arteriogenesis.
Lee MY; Gamez-Mendez A; Zhang J; Zhuang Z; Vinyard DJ; Kraehling J; Velazquez H; Brudvig GW; Kyriakides TR; Simons M; Sessa WC
Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):870-879. PubMed ID: 29449333
[TBL] [Abstract][Full Text] [Related]
16. Absence of the calcium-binding protein, S100A1, confers pulmonary hypertension in mice associated with endothelial dysfunction and apoptosis.
Teichert-Kuliszewska K; Tsoporis JN; Desjardins JF; Yin J; Wang L; Kuebler WM; Parker TG
Cardiovasc Res; 2015 Jan; 105(1):8-19. PubMed ID: 25395393
[TBL] [Abstract][Full Text] [Related]
17. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway.
Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ
Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703
[TBL] [Abstract][Full Text] [Related]
18. Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells.
Yan J; Tie G; Park B; Yan Y; Nowicki PT; Messina LM
J Vasc Surg; 2009 Dec; 50(6):1412-22. PubMed ID: 19837544
[TBL] [Abstract][Full Text] [Related]
19. Deletion of FHL2 gene impaired ischemia-induced blood flow recovery by modulating circulating proangiogenic cells.
Huang PH; Chen CY; Lin CP; Wang CH; Tsai HY; Lo WY; Leu HB; Chen JW; Lin SJ; Chu PH
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):709-17. PubMed ID: 23413425
[TBL] [Abstract][Full Text] [Related]
20. Neurotrophin-3 is a novel angiogenic factor capable of therapeutic neovascularization in a mouse model of limb ischemia.
Cristofaro B; Stone OA; Caporali A; Dawbarn D; Ieronimakis N; Reyes M; Madeddu P; Bates DO; Emanueli C
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1143-50. PubMed ID: 20360537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
